MEDtalks would like to keep you informed about the content that is most relevant to you.
Click here for more information.
ECTRIMS 2013 - Interview series 3
This interview is about, the 21-Year Study and Therapeutic Opportunities in Progressive MS.
This program is editorially independent and is financially made possible by
You can choose to block cookies. However, some cookies are essential
for the proper functioning of the website. By clicking "Accept" button, you confirm
to have read and accepted.
You can disable these cookies via your browser, see for example this explanation
by the Consumers for explanation
On acceptance: use all cookie settings
On denial: use only necessary cookies